Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Barcelona
Clinical trial register · Spain

Clinical Trials in Barcelona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5925 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:19 UTC
5925
Studies in scope
all four open statuses
3119
Recruiting now
open to new participants
1134
Lead sponsors
across recruiting studies
Top sites
Esplugues de Llobregat 1 Barcelona 1 Madrid 1 Seville 1 Valencia 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca189 Merck Sharp & Dohme LLC112 Novartis Pharmaceuticals106 Janssen Research & Development, LLC98 Eli Lilly and Company83 Hoffmann-La Roche82 Pfizer59 AbbVie58 Bristol-Myers Squibb57 GlaxoSmithKline56 Hospital Universitari Vall d'Hebron Research Institute48 Boehringer Ingelheim47 Sanofi46 Amgen40 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau39 Hospital Clinic of Barcelona37 Daiichi Sankyo32 Novo Nordisk A/S31 Gilead Sciences27 Regeneron Pharmaceuticals25 Incyte Corporation23 Fundacion Clinic per a la Recerca Biomédica22 argenx21 Parc de Salut Mar21 European Organisation for Research and Treatment of Cancer - EORTC20 Genmab20 Takeda19 Bayer18 Fundación EPIC17 BeOne Medicines16 BioNTech SE16 University of Barcelona15 Fundación GECP15 Alexion Pharmaceuticals, Inc.14 Fundació Sant Joan de Déu14 Ipsen14 Vall d'Hebron Institute of Oncology14 MedSIR13 Seagen, a wholly owned subsidiary of Pfizer13 PETHEMA Foundation12 Genentech, Inc.12 Abbott Medical Devices12 Celgene12 Exelixis11 Astellas Pharma Global Development, Inc.11 SOLTI Breast Cancer Research Group11 Taiho Oncology, Inc.10 Boston Scientific Corporation10 Universitat Internacional de Catalunya9 EMD Serono Research & Development Institute, Inc.9 Barcelonabeta Brain Research Center, Pasqual Maragall Foundation9 UCB Biopharma SRL9 Alnylam Pharmaceuticals9 Ionis Pharmaceuticals, Inc.9 ViiV Healthcare9 Institut de Recherches Internationales Servier8 Revolution Medicines, Inc.7 Consorci Sanitari de l'Alt Penedès i Garraf7 Loxo Oncology, Inc.7 Swedish Orphan Biovitrum7 Hospital Universitari de Bellvitge7 Mirum Pharmaceuticals, Inc.7 ETOP IBCSG Partners Foundation7 Biogen7 Eisai Inc.6 University Ramon Llull6 Jazz Pharmaceuticals6 Fundacion Dexeus6 Fundación Pública Andaluza para la gestión de la Investigación en Sevilla6 Mirati Therapeutics Inc.6 Princess Maxima Center for Pediatric Oncology6 MedImmune LLC6 Pierre Fabre Medicament6 Washington University School of Medicine6 Gustave Roussy, Cancer Campus, Grand Paris6 University Medical Center Groningen6 UNICANCER6 Deciphera Pharmaceuticals, LLC5 Alkermes, Inc.5 CatalYm GmbH5 Autolus Limited5 Ultragenyx Pharmaceutical Inc5 Replimune, Inc.5 Tesaro, Inc.5 Vertex Pharmaceuticals Incorporated5 Insel Gruppe AG, University Hospital Bern5 Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea5 Agios Pharmaceuticals, Inc.5 Immunocore Ltd5 Meyer Children's Hospital IRCCS5 Celldex Therapeutics5 Fundación para la Investigación del Hospital Clínico de Valencia5 University Hospital, Basel, Switzerland5 Consorcio Centro de Investigación Biomédica en Red (CIBER)5 Aragon Pharmaceuticals, Inc.5 Stichting Hemato-Oncologie voor Volwassenen Nederland5 H. Lundbeck A/S5 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company5 Kite, A Gilead Company5 Parc Sanitari Pere Virgili5 BioInvent International AB5 Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina4 Servier Bio-Innovation LLC4 Instituto de Investigación Hospital Universitario La Paz4 Otsuka Pharmaceutical Development & Commercialization, Inc.4 ADARx Pharmaceuticals, Inc.4 Ascentage Pharma Group Inc.4 Johnson & Johnson Enterprise Innovation Inc.4 Fundación Española de Hematología y Hemoterapía4 Acerta Pharma BV4 W.L.Gore & Associates4 Sarepta Therapeutics, Inc.4 Consorci Sanitari de Terrassa4 Denali Therapeutics Inc.4 Stemline Therapeutics, Inc.4 Institut d'Investigació Biomèdica de Bellvitge4 Immunovant Sciences GmbH4 Philogen S.p.A.4 Medtronic Cardiovascular4 Eikon Therapeutics4 Fundacio Privada Mon Clinic Barcelona4 CSL Behring4 Facultat de ciencies de la Salut Universitat Ramon Llull4 Centro Medico Teknon4 Grupo Espanol de Tumores Neuroendocrinos4 Alfasigma S.p.A.4 iVascular S.L.U.4 BicycleTx Limited4 RECORDATI GROUP4 European Myeloma Network B.V.4 Karuna Therapeutics, Inc., a Bristol Myers Squibb company4 Verastem, Inc.4 Fundacio Puigvert4 Cytokinetics4 Teva Branded Pharmaceutical Products R&D LLC3 Summit Therapeutics3 Zenas BioPharma (USA), LLC3 PharmaMar3 Karyopharm Therapeutics Inc3 Cogent Biosciences, Inc.3 Arcus Biosciences, Inc.3 Dr. Inge Winter3 Nuvalent Inc.3 Abivax S.A.3 Janssen Pharmaceutica N.V., Belgium3 Longboard Pharmaceuticals3 Fundación Santiago Dexeus Font3 Relay Therapeutics, Inc.3 Xencor, Inc.3 Azafaros B.V.3 BioMarin Pharmaceutical3 iOnctura3 Entrada Therapeutics, Inc.3 Population Health Research Institute3 Avalyn Pharma Inc.3 Inhibrx Biosciences, Inc3 ALX Oncology Inc.3 USWM CT, LLC3 IFOM ETS - The AIRC Institute of Molecular Oncology3 City of Hope Medical Center3 Shanghai Henlius Biotech3 International Extranodal Lymphoma Study Group (IELSG)3 Société des Produits Nestlé (SPN)3 Blueprint Medicines Corporation3 Celcuity Inc3 ArriVent BioPharma, Inc.3 Grupo Espanol de Investigacion en Sarcomas3 Travere Therapeutics, Inc.3 Syndax Pharmaceuticals3 Hospital del Mar3 Region Örebro County3 Alentis Therapeutics AG3 Enliven Therapeutics3 Hospital Vall d'Hebron3 EyeBiotech Ltd.3 Instituto de Investigación Biomédica de Salamanca3 Vividion Therapeutics, Inc.3 ITM Solucin GmbH3 Xenon Pharmaceuticals Inc.3 Weill Medical College of Cornell University3 Vir Biotechnology, Inc.3 Copenhagen University Hospital, Rigshospitalet3 Unity Health Toronto3 Medtronic3 Kura Oncology, Inc.3 AOP Orphan Pharmaceuticals AG3 GBG Forschungs GmbH3 Pyxis Oncology, Inc3 Arrowhead Pharmaceuticals3 Grupo Español Multidisciplinar de Melanoma3 Neurocrine Biosciences3 Institut d'Investigacions Biomèdiques August Pi i Sunyer2 Mediar Therapeutics2 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2 Biohaven Therapeutics Ltd.2 Nantes University Hospital2 Istituto Giannina Gaslini2 Ferring Pharmaceuticals2 Nelum Corp2 Universitat Autonoma de Barcelona2 Stichting European Myeloma Network2 Asociación Española para el Estudio del Hígado2 Tyra Biosciences, Inc2 Orion Corporation, Orion Pharma2 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc2 Pharming Technologies B.V.2 Akero Therapeutics, Inc2 Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz2 Zai Lab (Shanghai) Co., Ltd.2 Institut Investigacio Sanitaria Pere Virgili2 Chiesi Farmaceutici S.p.A.2 HistoSonics, Inc.2 Artios Pharma Ltd2 Fecundis Lab SL2 Lacer S.A.2 Merz Therapeutics GmbH2 Alliance Foundation Trials, LLC.2 Heidelberg University2 UMC Utrecht2 University Hospital, Geneva2 Biobizkaia Health Research Institute2 medac GmbH2 University College, London2 Kiniksa Pharmaceuticals International, plc2 Mats Heyman2 JCR Pharmaceuticals Co., Ltd.2 Puerta de Hierro University Hospital2 Italfarmaco2 Genzyme, a Sanofi Company2 University of Oxford2 Corcept Therapeutics2 Procare Health Iberia S.L.2 Epygenix2 Aarhus University Hospital Skejby2 Avidity Biosciences, Inc.2 Jesus Villar2 FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS2 Corbus Pharmaceuticals Inc.2 Alleviant Medical, Inc.2 Prilenia2 PTC Therapeutics2 University of Cologne2 European Clinical Research Alliance for Infectious Diseases (ECRAID)2 Jiangsu HengRui Medicine Co., Ltd.2 Byondis B.V.2 IO Biotech2 Italian Sarcoma Group2 University Health Network, Toronto2 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2 Sumitomo Pharma America, Inc.2 AO Innovation Translation Center2 AB Science2 Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal2 University Rovira i Virgili2 Universitätsklinikum Hamburg-Eppendorf2 mAbxience Research S.L.2 Zimmer Biomet2 European Foundation for Study of Chronic Liver Failure2 Hospital del Mar Research Institute (IMIM)2 Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD2 Puma Biotechnology, Inc.2 Astellas Pharma Inc2 Ellipses Pharma2 Dianthus Therapeutics2 Dyne Therapeutics2 MediLink Therapeutics (Suzhou) Co., Ltd.2 NovoCure GmbH2 Pharvaris Netherlands B.V.2 Association for Innovation and Biomedical Research on Light and Image2 Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2 PedAL BCU, LLC2 Ryvu Therapeutics SA2 Servei Central d'Anestesiologia2 Crinetics Pharmaceuticals Inc.2 Medical University of Vienna2 Colorado Prevention Center2 IRCCS Azienda Ospedaliero-Universitaria di Bologna2 Aelis Farma2 ADC Therapeutics S.A.2 Nuvation Bio Inc.2 Oncomatryx Biopharma S.L.2 Eidos Therapeutics, a BridgeBio company2 The Lymphoma Academic Research Organisation2 Harmony Biosciences Management, Inc.2 Almirall, S.A.2 GRIN Therapeutics, Inc.2 Turning Point Therapeutics, Inc.2 Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic2 Eva Bonfill2 AgNovos Healthcare, LLC2 Scholar Rock, Inc.2 Zymeworks BC Inc.2 CoreAalst BV2 Biotronik SE & Co. KG2 Anaconda Biomed S.L.2 Inmunotek S.L.2 Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León2 Vascutek Ltd.2 Actelion2 Viatris Innovation GmbH2 Hansa Biopharma AB2 Joseph Broderick, MD2 Alumis Inc2 Iovance Biotherapeutics, Inc.2 NeuroDerm Ltd.2 Advanced Accelerator Applications2 Grupo Español de Tratamiento de Tumores de Cabeza y Cuello2 Instituto de Investigación Marqués de Valdecilla2 Kardigan, Inc.2 Debiopharm International SA2 Aesculap AG2 Olema Oncology, Inc.2 AC Immune SA2 TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)2 ORIC Pharmaceuticals2 Chugai Pharmaceutical2 Kartos Therapeutics, Inc.2 Cullinan Therapeutics Inc.2 Kailera2 Maastricht University Medical Center2 Fundación Academia Española de Dermatología2 IRCCS San Raffaele2 United Therapeutics2 Basilea Pharmaceutica2 University Hospital, Montpellier2 University of Southern California2 Fundació Institut Germans Trias i Pujol2 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2 Ono Pharmaceutical Co., Ltd.2 OrbusNeich2 Apellis Pharmaceuticals, Inc.2 Gruppo Oncologico del Nord-Ovest2 Madrigal Pharmaceuticals, Inc.2 University of Vic - Central University of Catalonia2 SystImmune Inc.2 Institut National de la Santé Et de la Recherche Médicale, France2 IDP Discovery Pharma S.L.2 UroGen Pharma Ltd.2 European Association of Urology Research Foundation2 Dizal Pharmaceuticals2 Canadian Cancer Trials Group2 Fondazione Policlinico Universitario Agostino Gemelli IRCCS2 OncoVerity, Inc.2 P+F Products + Features GmbH2 The European Forum for Research and Education in Allergy and Airway Diseases1 Ricard Mellado Artigas1 Industrial Farmacéutica Cantabria, S.A.1 Azienda Ospedaliero-Universitaria Careggi1 McGill University Health Centre/Research Institute of the McGill University Health Centre1 V-Wave Ltd1 NS Pharma, Inc.1 Laboratoires Thea1 German Cancer Research Center1 Salubris Biotherapeutics Inc1 Xentria, Inc.1 Solstice Oncology, Inc.1 LMU Klinikum1 ImmunoVaccine Technologies, Inc. (IMV Inc.)1 Laminar Pharmaceuticals1 Terumo Europe N.V.1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Shanghai Golden Leaf MedTec Co. Ltd1 Anna Cruceta1 Helena Vall Roqué1 Adacyte Therapeutics SL1 Biocodex1 Prokrea BCN, S.L.1 MonTa Biosciences ApS1 Priothera SAS1 Reprieve Cardiovascular, Inc1 Newcastle University1 ExThera Medical Corporation1 Immutep S.A.S.1 Medtronic Neurovascular Clinical Affairs1 Actuate Therapeutics Inc.1 European Breast Cancer Research Association of Surgical Trialists1 Egle Therapeutics1 Establishment Labs1 Pliant Therapeutics, Inc.1 The Cleveland Clinic1 NEOS Surgery1 NEC Bio B.V1 Teknimed1 VahatiCor, Inc.1 Greece 2021 Committee1 GCA (Eurosilicone)1 Dren Bio1 BeiGene1 SpliSense Ltd.1 Batea Oncology1 Fundacio Clinic Barcelona1 University of Michigan1 The University of Texas Health Science Center, Houston1 Central Hospital, Nancy, France1 Oxford BioTherapeutics Ltd1 University of Milano Bicocca1 Fundación Sociedad Española de Oncologia Médica1 CMR Surgical Ltd1 VarmX B.V.1 Instituto Oncológico Dr Rosell1 Bicara Therapeutics1 Philips Clinical & Medical Affairs Global1 Y-mAbs Therapeutics1 McMaster University1 PPM Services S.A.1 University of Zurich1 Oncoinvent Solutions AS1 NEAT ID Foundation1 Lakefront Biotherapeutics NV1 Universidad Autonoma de Madrid1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Eclipse Medical Ltd.1 enGene, Inc.1 Tesai Care SL1 Mayo Clinic1 Advenchen Pharmaceuticals, LLC.1 Interlinked AB1 Kyowa Kirin Pharmaceutical Development Ltd1 Philipp Schuetz1 Medical University of Graz1 Orthofix s.r.l.1 Tectonic Operating Company, Inc.1 Agenus Inc.1 Exactech1 Humanitas Hospital, Italy1 Renaissance Pharma Ltd.1 Mundipharma Research Limited1 Nurix Therapeutics, Inc.1 D3 Bio (Wuxi) Co., Ltd1 Elpida Therapeutics SPC1 GWT-TUD GmbH1 Guardant Health, Inc.1 Shockwave Medical, Inc.1 Leiden University Medical Center1 Institut Català de Traumatologia i Medicina de l'Esport1 Galderma R&D1 Kumquat Biosciences Inc.1 Medtronic - MITG1 NTC srl1 Repertoire Immune Medicines1 Hospital de Sant Rafael1 AviadoBio Ltd1 Judit Pich1 AtriCure, Inc.1 University of Siena1 Orphalan1 Ciliatech1 Zogenix, Inc.1 Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)1 Checkpoint Therapeutics, Inc.1 Universitätsmedizin Mannheim1 MoonLake Immunotherapeutics AG1 National University of Singapore1 King's College London1 Göteborg University1 Marengo Therapeutics, Inc.1 RayzeBio, Inc.1 Prothya Biosolutions1 Reinier de Graaf Groep1 Biocon Biologics UK PLC1 University of Mons1 Quell Therapeutics Limited1 Aura Biosciences1 Fidia Farmaceutici s.p.a.1 Geron Corporation1 Edgewise Therapeutics, Inc.1 MOMA Therapeutics1 CardioRenal Systems, Inc.1 Immunome, Inc.1 JOTEC GmbH1 Instituto Médico Tecnológico SL1 Savara Inc.1 Xeltis1 Peptomyc S.L.1 UCB BIOSCIENCES, Inc.1 World Medica USA, LLC1 Anthos Therapeutics, Inc.1 Target PharmaSolutions, Inc.1 Gruppo Italiano Malattie EMatologiche dell'Adulto1 Ocus Innovation Ireland Limited1 Ad scientiam1 Tenax Therapeutics, Inc.1 Dr. Yaroslav Winter1 Imbria Pharmaceuticals, Inc.1 Leukos Biotech S.L.1 Hamilton Health Sciences Corporation1 Idoven 1903 S.L.1 Ophtec BV1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 Pharmacyclics Switzerland GmbH1 Hospital HM Nou Delfos1 AriBio Co., Ltd.1 Quetzal Therapeutics1 Liquidia Technologies, Inc.1 Nordberg Medical AB1 Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta1 SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 University of Utah1 Panbela Therapeutics, Inc.1 Praxis Precision Medicines1 AIRNA Corporation1 University of Birmingham1 MicroPort Orthopedics Inc.1 Institut für Pharmakologie und Präventive Medizin1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 MaaT Pharma1 Kliniken Beelitz GmbH1 Prostate Cancer Clinical Trials Consortium1 Tango Therapeutics, Inc.1 Medicenna Therapeutics, Inc.1 C4 Therapeutics, Inc.1 University of British Columbia1 Spanish Oncology Genito-Urinary Group1 Xcovery Holdings, Inc.1 AUSL Romagna Rimini1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 CanariaBio Inc.1 Generate Biomedicines1 Janssen Biotech, Inc.1 eleva GmbH1 Parnassia Groep1 Xynomic Pharmaceuticals, Inc.1 iPremom1 Orthofix Inc.1 NewAmsterdam Pharma1 Pharmazz, Inc.1 Philipp Dutkowski1 Inari Medical1 Medtronic Cardiac Surgery1 Tobias Feuchtinger1 David Garcia Cinca1 Pharmanutra S.p.a.1 Intellia Therapeutics1 DR Healthcare - biotexia1 Schrödinger, Inc.1 CRISPR Therapeutics AG1 Paris Translational Research Center for Organ Transplantation1 OncoSil Medical Limited1 Institut Català d'Oncologia1 Jesús Manuel Nieves Alonso1 Centre hospitalier de l'Université de Montréal (CHUM)1 Fondazione Ricerca Traslazionale1 University of Malaga1 Stalicla SA1 Medtronic Cardiac Ablation Solutions1 Anthogyr1 Nobel Biocare1 Institut Catala de Retina1 Multiple Sclerosis Center of Catalonia1 University of Leicester1 Oriol Manuel1 Pedro Victor López Plaza1 Maurizio Tonetti1 Bioprojet1 University Hospital of Cologne1 HUYABIO International, LLC.1 Qilu Pharmaceutical Co., Ltd.1 Noah Labs1 Totus Medicines1 X4 Pharmaceuticals1 Universitaire Ziekenhuizen KU Leuven1 Fundación de investigación HM1 Inotrem1 EDUARDO ALBENIZ1 Delcath Systems Inc.1 Spanish Lung Cancer Group1 Institute of Cancer Research, United Kingdom1 Eodyne Systems SL1 GELLC (Grupo Español de Leucemia Linfocítica Crónica)1 4C Medical Technologies, Inc.1 Change Accelerator in Respiratory Care1 OnKure, Inc.1 ONL Therapeutics1 Tanabe Pharma America, Inc.1 Escola Universitària d'Infermeria i Teràpia Ocupacional de Terrassa1 Helena DOMINGUEZ1 Recornea Srl1 Leica Microsystems (Schweiz) AG1 Spur Therapeutics1 Jakob Stenman1 Niguarda Hospital1 ParVation Therapeutics, Inc.1 Predictheon Medical, S.L.1 Istituto Italiano di Tecnologia1 Terremoto Biosciences Inc.1 Oruka Therapeutics, Inc.1 4TEEN4 Pharmaceuticals GmbH1 Janssen-Cilag Ltd.1 Grupo Español de Investigación en Neurooncología1 Dompé Farmaceutici S.p.A1 Iria Grande1 Michael J. Fox Foundation for Parkinson's Research1 David Gallardo-Pujol1 Poitiers University Hospital1 Noucor Health S.A.1 Linkoeping University1 Swiss GO Trial Group1 Advesya SAS1 Charite University, Berlin, Germany1 Connecta Therapeutics, S.L.1 Merida Biosciences1 Institut Claudius Regaud1 AskBio Inc1 Salvat1 Dentsply Sirona Implants and Consumables1 Pheon Therapeutics1 Cerevance1 iECURE, Inc.1 Arbor Research Collaborative for Health1 Aleksander Krag1 Annetine Gelijns1 LeonaBio1 SynOx Therapeutics Limited1 Amicus Therapeutics1 Rezolute1 SOTIO Biotech AG1 OneChain Immunotherapeutics1 Fitoplancton Marino, S.L.1 CEBIOTEX1 San Raffaele University1 Vaderis Therapeutics AG1 Fundación Canaria Instituto de Investigación Sanitaria de Canarias1 Alejandro Cruz Utrilla1 University Hospital, Grenoble1 Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias1 Boston Children's Hospital1 Radboud University Medical Center1 Fundación IVI1 AFT Pharmaceuticals, Ltd.1 Gabriel Riva1 Mestag Therapeutics Limited1 Transgene1 Probelte Pharma S.L.U.1 SecuraBio1 WhiteSwell, Limited1 Akcea Therapeutics1 Diagram B.V.1 Elizabeth Kilbey1 Astria Therapeutics, Inc.1 Nykode Therapeutics ASA1 Integrative Research Laboratories AB1 University Medical Center Nijmegen1 Highlight Therapeutics1 Acrotech Biopharma Inc.1 NMD Pharma A/S1 DBV Technologies1 Hellenic Institute for the Study of Sepsis1 University Hospital Muenster1 National Cancer Institute (NCI)1 Medtronic MiniMed, Inc.1 Acrivon Therapeutics1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Womed1 Gradient Denervation Technologies1 Apogee Therapeutics, Inc.1 MiMARK Diagnostics, S.L.1 NORCE Norwegian Research Centre AS1 Alterome Therapeutics, Inc.1 Moleculin Biotech, Inc.1 Ascendis Pharma A/S1 Wim Janssens1 VisionCare, Inc.1 Uniquity One (UNI)1 TransThera Sciences (Nanjing), Inc.1 ADVANCED MARKER DISCOVERY S.L.1 Milestone Pharmaceuticals Inc.1 invoX Pharma Limited1 Wandercraft1 Greenwich LifeSciences, Inc.1 Children's Oncology Group1 Cook Research Incorporated1 Alliance for Clinical Trials in Oncology1 Francisco J. Blanco1 Stephanie Grasso1 University of Manitoba1 Vifor Fresenius Medical Care Renal Pharma1 Deepull Diagnostics S.L.1 University of Edinburgh1 Occlutech International AB1 Verici Dx1 Maquet Cardiovascular1 Upstream Bio Inc.1 Zura Bio Inc1 Hidde van der Ploeg1 IDRX, Inc., a wholly owned subsidiary of GSK, LLC1 Johns Hopkins University1 Montse Palacio1 Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Cellectar Biosciences, Inc.1 German Heart Institute1 Memorial Sloan Kettering Cancer Center1 Philippe ROUSSELOT1 AusperBio Therapeutics Inc.1 Sun Pharmaceutical Industries Limited1 Miltenyi Biomedicine GmbH1 ABLE Human Motion S.L.1 ABX advanced biochemical compounds GmbH1 Weizmann Institute of Science1 Clarity Health Technologies, Inc1 Apollomics Inc.1 CHDI Foundation, Inc.1 Innovacell GmbH1 Maria Joyera Rodríguez1 PedNet Haemophilia Research Foundation1 SymBio Pharmaceuticals1 Resolution Therapeutics Limited1 T.O.A.D. Oncology SA1 DualityBio Inc.1 Tenaya Therapeutics1 European Institute of Oncology1 Ultrasound-Innovation Medtech, S.L.1 Protagonist Therapeutics, Inc.1 Sanofi Pasteur, a Sanofi Company1 ITB-Med LLC1 Skyhawk Therapeutics, Inc.1 Astellas Gene Therapies1 Biotronik AG1 Silence Therapeutics plc1 Qurient Co., Ltd.1 Gyala Therapeutics1 Rijnstate Hospital1 Centre Hospitalier Universitaire de Besancon1 GCP-Service International West GmbH1 CUTISS AG1 Joan Sabater-Riera1 IRCCS Sacro Cuore Don Calabria di Negrar1 Esteve Pharmaceuticals, S.A.1 Baxalta now part of Shire1 Iperboreal Pharma Srl1 Redx Pharma Ltd1 35Pharma Inc., a GSK company1 Tharick Pascoal1 Nouscom SRL1 National University of Ireland, Galway, Ireland1 Viridian Therapeutics, Inc.1 Medtronic Spinal and Biologics1 Federation Francophone de Cancerologie Digestive1 Citryll BV1 Vedanta Biosciences, Inc.1 Acumen Pharmaceuticals1 Igenomix1 Shenzhen Lifevalve Medical Scientific Co., Ltd.1 Fundación de Investigación Biomédica - Hospital Universitario de La Princesa1 Tectonic Therapeutic1 Satellos Bioscience, Inc.1 ModernaTX, Inc.1 Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Fundación Española de Medicina1 ARTIDIS AG1 Klus Pharma Inc.1 Rotkreuzklinikum München gGmbH1 iTeos Therapeutics1 National Institute of Oncology, Hungary1 Rob Surgical Systems S.L.1 Devintec Sagl1 European Society for Trauma and Emergency Surgery1 Skin Tech Pharma Group S.L.U.1 PhenoNet, Inc.1 Crystalys Therapeutics1 University of Deusto1 Octapharma1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 University of Rochester1 Rigel Pharmaceuticals1 Biointelligent Technology Systems SL1 Steba Biotech S.A.1 Outcomes'101 K36 Therapeutics, Inc.1 Inventiva Pharma1 Ottimo Pharma Limited1 Erasca, Inc.1 GLSMED Learning Health S.A.1 Advanced NanoTherapies1 Albireo, an Ipsen Company1 Axon Therapies, Inc.1 Treeline Biosciences, Inc.1 AlgoTherapeutix1 Calico Life Sciences LLC1 Grupo Español de Rehabilitación Multimodal1 DGM Vascular1 King's College Hospital NHS Trust1 CellCentric Ltd.1 University of Cyprus1 Intra-Cellular Therapies, Inc.1 Arafarma Group, S.A.1 A Thousand Colibris, S.L1 Centre Besai1 Nimbus Wadjet, Inc.1 University of Alberta1 Myopowers Medical Technologies France SAS1 Eagle Pharmaceuticals, Inc.1 Elios Vision, Inc.1 Synthekine1 Fondazione Michelangelo1 Icahn School of Medicine at Mount Sinai1 Hospital Universitario Central de Asturias1 Ascendis Pharma Oncology Division A/S1 RTI Surgical1 Forma Therapeutics, Inc.1 Vor Biopharma1 Noema Pharma AG1 Biosensors Europe SA1 Grey Wolf Therapeutics1 Sunnybrook Health Sciences Centre1 LEO Pharma1 Women's Cancer Study Group GmbH1 Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 AVEO Pharmaceuticals, Inc.1 Germans Trias i Pujol Hospital1 Exciva GmbH1 Atea Pharmaceuticals, Inc.1 Fundacion Oncosur1 JRI Orthopaedics1 Epizyme, Inc.1 Iambic Therapeutics, Inc1 Balton Sp.zo.o.1 pharmaand GmbH1 Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 AO Foundation, AO Spine1 Incyte Biosciences International Sàrl1 Juan M Garcia-Gomez1 Abbisko Therapeutics Co, Ltd1 Fundacion IMIM1 M.D. Anderson Cancer Center1 Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús1 Profound Medical Inc.1 M.A. Med Alliance S.A.1 Alba Roca1 Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital1 Abalos Therapeutics GmbH1 Dimerix Bioscience Pty Ltd1 ARCAGY/ GINECO GROUP1 Persei Vivarium1 Xinnate AB1 Cardiac Dimensions, Inc.1 Gossamer Bio USA, Inc.1 Olatec Therapeutics, Inc.1 Airway Therapeutics, Inc.1 German CLL Study Group1 RapidPulse, Inc1 RyCarma Therapeutics, Inc.1 Stealth BioTherapeutics Inc.1 Accession Therapeutics Limited1 T3 Pharmaceuticals AG1 HiFiBiO Therapeutics1 Shanghai Junshi Bioscience Co., Ltd.1 Contineum Therapeutics1 Prelude Therapeutics Incorporated1 Centro Nacional de Investigaciones Oncologicas CARLOS III1 Advenchen Laboratories, LLC1 Insmed Incorporated1 Crescent Biopharma, Inc.1 Hospital General Universitario de Alicante1 4D Molecular Therapeutics1 Vastra Gotaland Region1 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)1 Danone Global Research & Innovation Center1 Mitra Bio1 Science Corporation1 diana garcia1 Grupo Espanol Multidisciplinario del Cancer Digestivo1 Corxel Pharmaceuticals1 Luis Eduardo Estévez Cachafeiro1 Gyroscope Therapeutics Limited1 OSE Immunotherapeutics1 Adcytherix SAS1 Duke Street Bio Ltd1 Rovi Pharmaceuticals Laboratories1 Fundació ACE Institut Català de Neurociències Aplicades1 MiWEndo Solutions S.L.1 Partner Therapeutics, Inc.1 University of Bologna1 Ichnos Sciences SA1 Rocket Pharmaceuticals Inc.1 CStone Pharmaceuticals1 Fundació d'investigació Sanitària de les Illes Balears1 Biotest1 HotSpot Therapeutics, Inc1 Samsung Bioepis Co., Ltd.1 Disc Medicine, Inc1 Intensity Therapeutics, Inc.1 Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas1 PMV Pharmaceuticals, Inc1 Fore Biotherapeutics1 Arvinas Inc.1 COMPASS Pathways1 Imagine Institute1 Francesc Colom, PsyD, PhD1 Hospital Clínico Universitario de Valladolid1 DiaMedica Therapeutics Inc1 Elion Therapeutics, Inc.1 Australasian Gastro-Intestinal Trials Group1 CarThera1 Indiana University1 Somagenetix AG1 ReSport Clinic1 University of Maryland, Baltimore1 Cartesian Therapeutics1 University of Manchester1 Epics Therapeutics1 Guerbet1 Premium Fertility1 Infanta Leonor University Hospital1 Ivy Brain Tumor Center1 Annexon, Inc.1 Neuron23 Inc.1 Day One Biopharmaceuticals, Inc.1 CytoSorbents, Inc1 ImCheck Therapeutics, an Ipsen company1 Priovant Therapeutics, Inc.1 Assistance Publique - Hôpitaux de Paris1 Smith & Nephew, Inc.1 Vecmedical Spain, S.L.1 Servier Affaires Médicales1 Spanish Breast Cancer Research Group1 Friedreich's Ataxia Research Alliance1 Camurus AB1 Hospital San Carlos, Madrid1 BioLineRx, Ltd.1 Jules Bordet Institute1 Eledon Pharmaceuticals1 University of Campania Luigi Vanvitelli1 Societat Catalana de Medicina Familiar i Comunitària, Assoc. (CAMFiC)1 St. Anna Kinderkrebsforschung1 University of Seville1 Aptose Biosciences Inc.1 Zydus Therapeutics Inc.1 Grupo Español de Investigación en Cáncer de Ovario1 One-carbon Therapeutics AB1 Martin Huelsmann1 Galaxy Therapeutics INC1 BioAegis Therapeutics Inc.1 Hospital General Universitario Gregorio Marañon1 ReCor Medical, Inc.1 Epygon1 Boston University1 Rapamycin Holdings Inc.1 Inhibikase Therapeutics1 Åslaug Helland1 Glaukos Corporation1 Enterome1 Prevail Therapeutics1 Breast Cancer Trials, Australia and New Zealand1 Menarini Group1 Bold Therapeutics, Inc.1 Curis, Inc.1 Prof. Valérie Mc Lin1 Inhatarget Therapeutics1 Elevar Therapeutics1 Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company1 Fertiga, Belgium1 Felix Perez Tejera1 Fundación para la Investigación Biosanitaria del Principado de Asturias1 Beeline Medicines Corporation1 Fundació Universitària del Bages1 Genespire Srl1 MediWound Ltd1 Calluna Pharma AS1 Britannia Pharmaceuticals Ltd.1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 i+Med S.Coop.1 Applied Therapeutics, Inc.1 CDR-Life AG1 Alligator Bioscience AB1 Clear sponsor filter
Target enrolment
to

Trials with a site in Barcelona

1 of 5925 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Active, closed
CEB-01 in Locally Resectable Pancreatic Cancer
NCT06538857Pancreatic Carcinoma
DrugCEB-01
CEBIOTEX
Early Phase 1
39
Barcelona, Madrid, Seville, Valencia
2024-08-20
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-spain/city/barcelona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,925 studies in total at the last sync on 20 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Barcelona that also match the filters currently applied.

How many clinical trials are recruiting in Barcelona?

0 of the 1 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Barcelona), 1 studies
PhaseStudiesRecruitingShare
Early Phase 110100%

Most active sponsors

Lead sponsors with the most studies (Barcelona)
Lead sponsorStudiesRecruiting
CEBIOTEX10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.